TY - JOUR
T1 - Fibronectin in tissue regeneration
T2 - Timely disassembly of the scaffold is necessary to complete the build
AU - Stoffels, Josephine M.J.
AU - Zhao, Chao
AU - Baron, Wia
N1 - Funding Information: Work in the Baron Laboratory is supported by grants from the Netherlands Foundation for the Support of MS Research (Stichting MS Research), and the Netherlands Organization of Scientific Research NWO (VIDI and Aspasia).
PY - 2013/11
Y1 - 2013/11
N2 - Tissue injury initiates extracellular matrix molecule expression, including fibronectin production by local cells and fibronectin leakage from plasma. To benefit tissue regeneration, fibronectin promotes opsonization of tissue debris, migration, proliferation, and contraction of cells involved in the healing process, as well as angiogenesis. When regeneration proceeds, the fibronectin matrix is fully degraded. However, in a diseased environment, fibronectin clearance is often disturbed, allowing structural variants to persist and contribute to disease progression and failure of regeneration. Here, we discuss first how fibronectin helps tissue regeneration, with a focus on normal cutaneous wound healing as an example of complete tissue recovery. Then, we continue to argue that, although the fibronectin matrix generated following cartilage and central nervous system white matter (myelin) injury initially benefits regeneration, fibronectin clearance is incomplete in chronic wounds (skin), osteoarthritis (cartilage), and multiple sclerosis (myelin). Fibronectin fragments or aggregates persist, which impair tissue regeneration. The similarities in fibronectin-mediated mechanisms of frustrated regeneration indicate that complete fibronectin clearance is a prerequisite for recovery in any tissue. Also, they provide common targets for developing therapeutic strategies in regenerative medicine.
AB - Tissue injury initiates extracellular matrix molecule expression, including fibronectin production by local cells and fibronectin leakage from plasma. To benefit tissue regeneration, fibronectin promotes opsonization of tissue debris, migration, proliferation, and contraction of cells involved in the healing process, as well as angiogenesis. When regeneration proceeds, the fibronectin matrix is fully degraded. However, in a diseased environment, fibronectin clearance is often disturbed, allowing structural variants to persist and contribute to disease progression and failure of regeneration. Here, we discuss first how fibronectin helps tissue regeneration, with a focus on normal cutaneous wound healing as an example of complete tissue recovery. Then, we continue to argue that, although the fibronectin matrix generated following cartilage and central nervous system white matter (myelin) injury initially benefits regeneration, fibronectin clearance is incomplete in chronic wounds (skin), osteoarthritis (cartilage), and multiple sclerosis (myelin). Fibronectin fragments or aggregates persist, which impair tissue regeneration. The similarities in fibronectin-mediated mechanisms of frustrated regeneration indicate that complete fibronectin clearance is a prerequisite for recovery in any tissue. Also, they provide common targets for developing therapeutic strategies in regenerative medicine.
KW - Fibronectin
KW - Multiple sclerosis
KW - Osteoarthritis
KW - Tissue regeneration
KW - Wound healing
UR - http://www.scopus.com/inward/record.url?scp=84887083278&partnerID=8YFLogxK
U2 - https://doi.org/10.1007/s00018-013-1350-0
DO - https://doi.org/10.1007/s00018-013-1350-0
M3 - Review article
C2 - 23756580
SN - 1420-682X
VL - 70
SP - 4243
EP - 4253
JO - Cellular and Molecular Life Sciences
JF - Cellular and Molecular Life Sciences
IS - 22
ER -